-- Stocks in Switzerland Advance for a Third Day
-- B y   T o m   S t o u k a s
-- 2013-07-10T14:27:03Z
-- http://www.bloomberg.com/news/2013-07-10/swiss-stocks-rally-for-third-day-smi-at-five-week-high.html
Stocks in Switzerland  gained for a
third day as investors weighed  China ’s trade data and awaited
the minutes of the  Federal Reserve ’s June meeting.  Julius Baer  Group Ltd. and  Novartis AG (NOVN)  led gaining shares.
 Actelion Ltd. (ATLN)  snapped its longest winning streak ever.  Lonza
Group AG (LONN)  fell 1.7 percent after being added to UBS AG’s least
preferred list.  The  Swiss Market Index (SMI)  rose 0.2 percent to 7,962.68 at 4:25
p.m in Zurich, its highest level since May 31. The gauge has
rallied 2.3 percent so far this week amid optimism economic data
and corporate earnings will improve. The broader Swiss
Performance Index added 0.2 percent today.  “If you look at the China data, it doesn’t look so good as
it clearly signals a slower growth trend,” said Alessandro Fezzi, senior market analyst at LGT Bank Schweiz AG in Zurich.
“There is hope for more details from the Fed minutes on the
planned tapering.”  The volume of shares changing hands in SMI-listed companies
was 31 percent lower than the 30-day average today, according to
data compiled by Bloomberg.  The Federal Reserve releases the minutes of its June 18-19
meeting at 2 p.m. Washington time today. Speaking after that
meeting, Chairman  Ben S. Bernanke  said the central bank may pare
its $85 billion of monthly bond purchases this year and end them
by mid-2014 if the  U.S. economy  performs as the Fed forecasts.  China Trade  In China, a report from the General Administration of
Customs in Beijing showed that China’s exports in June fell 3.1
percent from a year earlier. The median estimate in a Bloomberg
survey had called for a 3.7 percent gain. Imports dropped 0.7
percent last month, compared with the median projection of a 6
percent increase.  Julius Baer, the third-largest wealth manager in
Switzerland, rose 1 percent to 39.13 Swiss francs. It has added
5.7 percent in the last three days.  Novartis advanced 0.9 percent to 69.75 francs, advancing
for a third day. The drugmaker has rallied 21 percent so far
this year.  Leclanche SA climbed 4 percent to 4.66 francs. The century-old battery maker rose 44 percent yesterday after securing a 17
million-franc ($17.6-million) loan.  Bachem Holding AG jumped 4.8 percent to 41.80 francs. The
maker of pharmaceutical ingredients said it found a simpler way
to make a multiple sclerosis drug with a global market of more
than $4 billion.  Actelion, the drug manufacturer, dropped 0.6 percent to
59.55 Swiss francs, snapping 11 days of gains.  Lonza fell 1.7 percent to 73.75 francs after UBS added the
drug-ingredients maker to its “least preferred” list ahead of
first-half results on July 25.  To contact the reporter on this story:
Tom Stoukas in Athens at 
 astoukas@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  